Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT04176198 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Sumitomo Pharma America, Inc. |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT04176198 is currently recruiting participants. This clinical trial study for myelofibrosis is actively seeking new participants at 32 locations across the United States. The study is sponsored by Sumitomo Pharma America, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04176198 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04176198 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.